Biobank/Genomic Research in Nigeria: Examining Relevant Privacy and Confidentiality Frameworks

National Human Genome Research Institute (NHGRI), “International HapMap Project,” available at <http://www.genome.gov/10001688> (last visited November 6, 2015).

de Vries J. Abayomi A. Littler K. , “Addressing Ethical Issues in H3Africa Research – The Views of Research Ethics Committee Members,” The Hugo Journal 9, no. 1 (2015): 1–4, at 1 [hereinafter cited as de Vries et al.].

United Nations Development Reports (UNDP), Human Development Report 2014: Sustaining Human Progress: Reducing Vulnerabilities and Building Resilience (New York: UNDP, 2014): At 218 [hereinafter cited as UNDP].

Id., at 216–219.

Central Intelligence Agency (CIA), “World Factbook: Nigeria,” available at <https://www.cia.gov/library/publications/the-world-factbook/geos/ni.html> (last visited November 6, 2015).

Forbes , “Nigeria: Profile,” December 2014, available at <http://www.forbes.com/places/nigeria/> (last visited November 6, 2015).

PwC Economics, “World in 2050, the BRICs and Beyond: Prospects, Challenges and Opportunities,” at 2, January 2013, available at <http://www.eldis.org/go/home&id=66757&type=Document#.VXhQy_lVhBd> (last visited November 6, 2015).

U.S. Energy Information and Administration (IEA), Country Analysis Brief: Nigeria , at 1, available at <http://www.eia.gov/countries/analysisbriefs/Nigeria/nigeria.pdf> (last visited November 6, 2015).

Federal Ministry of Health (FMoH), National Health Policy 2004, ¶ 4.6 [hereinafter cited as National Health Policy].

Id., at ¶ 3.3.

National Health Act, (SB. 215) 2014, § 1(1)(c) [hereinafter cited as National Health Act].

See National Health Policy, supra note 10, at ¶ 3.2; Id., §1(1)(e).

See National Health Policy, supra note 10, at ¶ 3.1.

For a definition of MMR, see WHO, ICD-10 International Statistical Classification of Diseases and Related Health Problems (Malta: WHO, 2010): At 98.

World Health Organization (WHO), World Health Statistics 2014 (Geneva: WHO, 2014): At 82.

Id., at 90.

Figure derived from deducting 900 (equals 75 percent of MMR in 1990, which was 1200).

See UNDP, supra note 3, at 180.

Id., at 190.

Institute of Human Virology, Nigeria, Bio-repository Unit, available at <http://ihvnigeria.org/ihvnweb/webnew/index.php/officesdepts/clinical-lab-dept/bio-repository-unit.html> (last visited November 6, 2015).

Yakubu A. Adebamowo C. A. , “Implementing National System of Health Research Ethics Regulation: The Nigerian Experience,” BeOnline Journal, 1, no. 1 (2012): 4–15 [hereinafter cited as Yakubu and Adebamowo].

Federal Ministry of Health (FMoH), National Code of Health Research Ethics, at 1, August 13, 2007 [hereinafter cited as National Code of Health Research Ethics].

See National Health Act, supra note 14, at § 33.

Id., at § 33(6).

Id., at § 34(1).

Id., at § 34(2).

See National Code of Health Research Ethics, supra note 31, at v.

Council for International Organizations of Medical Sciences (CIOMS), International Ethical Guidelines for Biomedical Research Involving Human Subjects, 1993 [hereinafter cited as CIOMS].

World Medical Association (WMA), Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects , 64th WMA General Assembly, Fortaleza, Brazil, October 2013, available at <http://www.wma.net/en/30publications/10policies/b3/> (last visited November 6, 2015) [hereinafter cited as Declaration of Helsinki].

Code of Federal Regulations, Title 45, Part 46, Protection of Human Subjects, July 14, 2009.

Indian Council of Medical Research, Ethical Guidelines for Biomedical Research on Human Participants , 2006, available at <http://icmr.nic.in/ethical_guidelines.pdf> (last visited November 6, 2015).

Department of Health, Ethics in Health Research: Principles, Structures and Processes, available at <http://www.mrc.ac.za/ethics/DOHEthics.pdf> (last visited November 6, 2015).

See Yakubu Adebamowo , supra note 29.

See National Code of Health Research Ethics, supra note 31, at 10–11.

Id., at 3.

Id., at 15.

Id., at 14.

Id., at 17.

Id., at 20.

Id., at 20–21.

Id., at 24.

Id., at 37.

Id., at 38.

Id., at 39.

See CIOMS, supra note 38, at Guideline 3 (Commentary on Guideline 3).

See National Code of Health Research Ethics, supra note 31, at 40.

Id., at 28.

Id., at 29.

Id., at 31.

National Health Research Ethics Committee of Nigeria (NHREC), Policy Statement on Storage of Human Samples in Biobanks and Biorepositories in Nigeria (PS1.02013) , at 1, November 1, 2013 [hereinafter cited as NHREC].

Id., at 2.

Id., at 1.

Id., at 2–3.

Id., at 3.

See de Vries , supra note 2, at 2.

See NHREC, supra note 67, at 3.

Id., at 3–4.

Id., at 4.

See National Health Act, supra note 14, at § 33(1).

See NHREC, supra note 67, at 2.

Id., at 1.

See National Health Act, supra note 14, at § 26.

See NHREC, supra note 67, at 3–4.

Matimba A. Oluka M. N. Ebeshi B. U. , “Establishment of a Biobank and Pharmacogenetics Database of African Populations,” European Journal of Human Genetics 16 (2008): 780–785, at 781.

See National Health Act, supra note 14, at § 32(1)(b).

See NHREC, supra note 67, at 3.

See National Code of Health Research Ethics, supra note 31, at 37.

See Declaration of Helsinki, supra note 39, at ¶ 32.

See National Code of Health Research Ethics, supra note 31, at 37–38.

See CIOMS, supra note 38, at Guideline 2 (Commentary on Guideline 2) and Guideline 3.

See National Code of Health Research Ethics, supra note 31, at 39.

See CIOMS, supra note 38, at Guideline 3.

Staunton C. Moodley K. , “Challenges in Biobank Governance in Sub-Sahara Africa,” BMC Medical Ethics 14, no. 35 (2013), available at <http://www.biomedcentral.com/14726939/14/35> (last visited November 6, 2015).

See NHREC, supra note 67, at 3.

Igbe M. A. Adebamowo C. A. , “Qualitative Study of Knowledge and Attitudes to Biobanking among Lay Persons in Nigeria,” BMC Medical Ethics 13, no. 27 (2012), available at <http://www.biomedcentral.com/1472–6939/13/27> (last visited November 6, 2015).

H3Africa Working Group on Ethics and Regulatory Issues for the Human Heredity and Health (H3Africa) Consortium, H3Africa Guidelines for Informed Consent , at 2, August 2013, available at <http://h3africa.org/images/FinalPoliciesDocuments/H3A%20WG%20Guidelines%20Informed%20Consent_FINAL_01082013.pdf> (last visited November 6, 2015) [hereinafter cited as H3Africa Working Group].

See NHREC, supra note 67, at 3.

See National Code of Health Research Ethics, supra note 31, at 24.

See H3Africa Working Group, supra note 98, at 2.

Id., at 15.

Id., at 9–10.

See National Health Act, supra note 14, § 32(1) (b).

See National Code of Health Research Ethics, supra note 31, at 39.

H3Africa Consortium, “Enabling the Genomic Revolution in Africa,” Science 344, no. 6190 (2014), available at <http://www.sciencemag.org/content/344/6190/1346> (last visited November 6, 2015).

World Health Organization (WHO), The World Health Report 2000 – Health System: Improving Performance (Geneva: WHO, 2014): At 152–154.